The company has been granted patents by South Korea, China & Canada, that will be valid through 2029, 2029 and 2031 respectively, for the treatment of neurodegenerative diseases.
first published: Sep 4, 2014 02:47 pm
A collection of the most-viewed Moneycontrol videos.

Live: Can Nifty continue to step up its move to fresh peaks? | Opening Bell

Live: Sensex, Nifty retreat after mounting on new lifetime highs | Closing Bell

Live: Will bulls take Nifty to fresh lifetime highs today? | Opening Bell

Live: Nifty sees best single day rally since June 2025, nears record high | Closing Bell
You are already a Moneycontrol Pro user.

